A dissolving suture senses wound stress and quiets inflammation in rodents

A new surgical suture reported in Science Bulletin this August does four jobs in one fiber. It closes the wound, senses how much mechanical strain the tissue is under, releases an anti-inflammatory compound as it heals, and then dissolves.

The work, from a Chinese team publishing in the journal's August 2026 issue (PMID 42629297), was tested in rodent models of skin and muscle injury. There is no human data and no clinical trial. The category, programmable and transient surgical materials, has just received a credible new anchor; hospitals are not about to stock smart sutures.

The thread stacks four functions in a core-sheath architecture. Its outer sheath is a mat of poly(L-lactic acid), or PLLA, nanofibers. PLLA is the same biodegradable polymer used in dissolvable stitches and some bone screws, but the team arranged the polymer chains in their piezoelectric β-phase, the crystalline form that converts mechanical stress into an electrical signal. Adding quercetin, a plant flavonoid found in onions and apples, does two things at once: it locks the β-phase in place through hydrogen bonding, which boosts and stabilizes the piezoelectric output, and it acts as the thread's anti-inflammatory payload as it slowly releases from the fiber.

A flexible hydrogel core acts as the electrode that picks up the signal and conducts it outward. In rodent skin and muscle wounds, the researchers tied the e-suture into incisions and tracked the electrical output as the animals moved. The signal rose and fell with mechanical strain on the healing tissue, giving a continuous, in-wound record of how hard the wound was being worked. No external battery or wire crosses the skin in the design; the readout path runs from the hydrogel electrode out through the surrounding tissue.

The same fibers were releasing quercetin into the surrounding tissue. In the rodent model, this release suppressed M1 macrophage polarization, the early inflammatory cell state that drives cytokine cascades and slows the switch to the repair phase of healing. The combined result in the animals was neovascularization, more orderly collagen deposition, and faster resolution of inflammation compared with control sutures.

A standard suture is a passive mechanical fastener: a length of thread that holds tissue together while the body heals. A programmable suture senses a variable, in this case mechanical strain, and either reports it, responds to it, or modulates the local biology. The e-suture in this paper does all three. That is a different design target than a dissolvable stitch that simply holds and disappears.

The field of transient bioelectronics, devices that dissolve after doing their job, has been chasing that combination for years. Skin-conformal sweat sensors, resorbable neural interfaces, and dissolvable cardiac pacemakers have all shown that biocompatible materials can do real electronic work before they disappear. A suture is the next obvious substrate: it sits in tissue for days to weeks, it spans a moving mechanical load, and the body is already trained to break it down. What the e-suture adds to that list is a single fiber that does the sensing, the local therapy, and the dissolution in one structural part.

Two engineering limits sit between the rodent result and a future suture pack. First, "wireless" in the paper's framing refers to the absence of a battery or a wired chip inside the wound. The readout itself still implies an external coupling, an antenna or a skin-conductive path, that has to be designed, sterilized, and made small enough to use at the bedside. That is its own development track, and the surgical-suite form factor is the harder half of the problem.

Second, "biodegradable" is on a materials-science timescale set by how fast PLLA hydrolyzes in tissue, not a human surgical-recovery one. The thread does not vanish in a week. It is engineered to vanish on a schedule that matches the wound's biology, which is a longer and more variable window than the phrase usually suggests. Surgeons will want a tight, predictable resorption window, and the chemistry of the β-phase has to survive that whole window.

The rodent result is real materials science. The next specific rung is a reader a surgeon can drape on a patient's skin without disrupting the operating field, and a sterilization protocol that does not destroy the piezoelectric β-phase in the process. Until that hardware exists, the e-suture is a category-defining paper, not a category-defining product.